Syngulon will be at BioFIT 2018 on December 4&5 in Lille, France.
BioFIT is both the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovations and the European marketplace for pre-seed, seed and Series A investment in the field of Life Sciences. Guy Hélin, CEO of Syngulon, is member of the Steering Committee of BioFIT. https://lnkd.in/gyamNmr
Syngulon is at the SusChem Brokerage Event 2018 on Tuesday 23 October 2018 in Brussels, Belgium.
SusChem’s vision is for a competitive and innovative Europe where Sustainable Chemistry, Biotechnology and enabling Digital technologies respond to Societal challenges by providing Sustainable solutions. https://lnkd.in/gcbvTcw
The SusChem Brokerage Event 2018 will take place on Tuesday 23 October 2018, at Hotel Le Plaza, in Brussels, Belgium
Syngulon is presenting a poster on "The Syngulon PARAGEN Collection:
A standardized synthetic bacteriocin gene library for rapid in vitro antimicrobial peptide production" at the 2018 Symposium of the Belgian Society for Microbiology, “Microbes in the Spotlight” on October 19 in Brussels, Belgium. https://lnkd.in/gT736kW
The 2018 Symposium of the Belgian Society for Microbiology , “Microbes in the Spotlight” , organized jointly with the National Committee for Microbiology, will be held on Friday October 19th at the Royal Academies for Science and the Arts of Belgium...
ERS Genomics Limited and Syngulon, a synthetic biology startup developing original genetic technologies using bacteriocins, announced today a non-exclusive license agreement which provides Syngulon with worldwide access to ERS’ CRISPR-Cas9 genome editing intellectual property for use in combination with Syngulon Patent Rights. ERS Genomics holds rights to the foundational CRISPR-Cas9 patent portfolio from Dr. Emmanuelle Charpentier, an inventor of the breakthrough gene-editing technology. https://lnkd.in/g9gr2yJ
ERS Genomics was formed to provide broad access to the foundational CRISPR-Cas 9 intellectual property held by Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use. LEARN MORE “CRISPR” refers to clustered regularly interspaced...
Philippe Gabant, Co-founder & CSO, is keynote speaker at the BMAT 2018, International Congress on Biochemistry & Microbiology Applied Technologies, on November 2 - 4, in Hammamet, Tunisia. https://lnkd.in/gunyD9e
BMAT’2018 provides a platform for academic communication in Biochemistry and Microbiology and offers the opportunity of young researchers to meet internationally renowned professors.
Syngulon will present a poster on "The Syngulon PARAGEN Collection: A standardized synthetic bacteriocin gene library for rapid in vitro antimicrobial peptide production" at Synthetic Biology UK 2018 on November 19&20 in Bristol, UK. https://lnkd.in/gDYnx_W
A joint Biochemical Society and BrisSynBio Scientific Meeting SBUK 2018 will showcase the very best of UK Synthetic Biology research and will create a focal point for the community. All attendees, particularly researchers in the early stages of their...
Syngulon is at Bacterial protein export 2018 (BPE2018), an international conference on September the 30th - October 3rd 2018 in Leuven, Belgium. https://lnkd.in/gqncSwj
BIO-Europe offers powerful opportunities at one conference for you to network with the right partners and bring together hundreds of the world’s most innovative leaders across the biotech value chain for high-level networking, prescheduled partnering...
Syngulon, member of GreenWin / IAR / BIO / TWB, will be at EFIB, the market leading annual event in Europe for Industrial Biotechnology and the Bioeconomy, on 16-18 October 2018 in Toulouse, France. https://efibforum.com/
Syngulon will present its technologies to improve microbial fermentation at the ECP Summer Summit 2018 on 25 September 2018, in Dusseldorf, Germany. https://lnkd.in/g5CdCBh